Article Synopsis

  • L. is a significant and controversial plant with a rich history of various uses, highlighting its value in academic, agricultural, pharmaceutical, and industrial fields.
  • We conducted a meta-analysis of genomics data, revealing that current genome assemblies are incomplete and poorly organized, with a large portion of genetic material missing or unmapped.
  • This study emphasizes the urgency for collaborative efforts to enhance the understanding of genetic and biochemical diversity in L., which is crucial for crop development.

Video Abstracts

Crime Pays But Botany Doesn't

September 8, 2020

182,465 views


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

L. is an important yet controversial plant with a long history of recreational, medicinal, industrial, and agricultural use, and together with its sister genus , it represents a group of plants with a myriad of academic, agricultural, pharmaceutical, industrial, and social interests. We have performed a meta-analysis of pooled published genomics data, andwe present a comprehensive literature review on the evolutionary history of and , including medicinal and industrial applications. We demonstrate that current genome assemblies are incomplete, with ∼10% missing, 10-25% unmapped, and 45S and 5S ribosomal DNA clusters as well as centromeres/satellite sequences not represented. These assemblies are also ordered at a low resolution, and their consensus quality clouds the accurate annotation of complete, partial, and pseudogenized gene copies. Considering the importance of genomics in the development of any crop, this analysis underlines the need for a coordinated effort to quantify the genetic and biochemical diversity of this species.

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-arplant-081519-040203DOI Listing

Publication Analysis

Top Keywords

medicinal industrial
8
genomics close
4
close relatives
4
relatives controversial
4
controversial plant
4
plant long
4
long history
4
history recreational
4
recreational medicinal
4
industrial agricultural
4

Similar Publications

Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.

Ther Innov Regul Sci

September 2025

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Introduction: During the COVID-19 pandemic, regulatory and market access actions were taken to expedite the market entry of COVID-19 medicines. This study aims to (i) capture multi-stakeholder views on these actions, and (ii) provide recommendations for future-proofing routine and health-emergency frameworks.

Methods: Semi-structured interviews were conducted with policy makers/advisors (i.

View Article and Find Full Text PDF

Alzheimer's disease (AD) represents a growing global health burden, underscoring the urgent need for reliable diagnostic and prognostic biomarkers. Although several disease-modifying treatments have recently become available, their effects remain limited, as they primarily delay rather than halt disease progression. Thus, the early and accurate identification of individuals at elevated risk for conversion to AD dementia is crucial to maximize the effectiveness of these therapies and to facilitate timely intervention strategies.

View Article and Find Full Text PDF

Background: Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.

Methods: This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer.

View Article and Find Full Text PDF